Vitamin Bs, one carbon metabolism and prostate cancer

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 14, 2010, Pages 1385-1392

  Donkena, K V ^a   Yuan, H ^b   Young, C Y F ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

DNA methylation; Folate; Folic acid; One carbon metabolism; Prostate cancer; SNP; Vitamin B12; Vitamin B6

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; DNA; FLUOROURACIL; FOLIC ACID; METHIONINE; METHOTREXATE; PYRIDOXINE; RIBOFLAVIN; VITAMIN B GROUP;

ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARBON METABOLISM; CLINICAL TRIAL; DNA METHYLATION; DNA SYNTHESIS; EPIGENETICS; GENE EXPRESSION; HUMAN; NEOPLASM; NONHUMAN; PROSTATE CANCER;

ANIMALS; CARBON; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROSTATIC NEOPLASMS; VITAMIN B COMPLEX;

EID: 78649864006     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710793564106     Document Type: Article

References (75)

1. Droz, J. P.; Balducci, L.; Bolla, M.; Emberton, M.; Fitzpatrick, J. M.; Joniau, S.; Kattan, M.W.; Monfardini, S.; Moul, J. W.; Naeim, A.; van Poppel, H.; Saad, F.; Sternberg, C. N. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. Crit. Rev. Oncol Hematol., 2010, 73, 68-91.
2. Mitchell, R. E.; Chang, S. S. Current controversies in the treatment of high-risk prostate cancer. Curr. Opin. Urol., 2008, 18, 263-268.
3. Klein, E. A. Chemoprevention of prostate cancer. Annu. Rev. Med., 2006, 57, 49-63.
4. Lippman, S. M.; Lee J. J. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res., 2006, 66, 2893-2903.
5. Shukla, S.; Gupta, S. Dietary agents in the chemoprevention of prostate cancer. Nutr. Cancer, 2005, 53, 18-32.
6. Thompson, I. M.; Tangen, C. M.; Goodman, P. J.; Lucia, M. S.; Klein, E.A. J. Chemoprevention of prostate cancer. Urol., 2009, 182, 499-507.
7. Lipscomb, J. Estimating the cost of cancer care in the United States: a work very much in progress. J. Natl. Cancer Inst., 2008, 100, 607-610.
8. Wilson, L. S.; Tesoro, R.; Elkin, E. P.; Sadetsky, N.; Broering, J. M.; Latini, D. M.; Du Chane, J.; Mody, R. R.; Carroll, P. R. Cumulative cost pattern comparison of prostate cancer treatments. Cancer, 2007, 109, 518-527.
9. Friso, S.; Choi, S. W. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab., 2005, 6, 37-46.
10. Selhub, J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging, 2002, 6, 39-42.
11. Powers, H. J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J. Nutr., 2005,135 (12 Suppl), 2960S-2966S.
12. Gregory, J. F. The bioavailability of folate. Folate in health and disease, Bailey, L.B. Ed. Marcel Dekker, New York 1995.
13. Wright, A. J.; Dainty, J. R.; Finglas, P. M. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br. J. Nutr., 2007, 98, 667-675.
14. van Guelpen, B. Folate in colorectal cancer, prostate cancer and cardiovascular disease. Scand. J. Clin. Lab. Invest., 2007, 67, 459-473.
15. Hubner, R. A.; Houlston, R. S. Folate and colorectal cancer prevention. Br. J. Cancer, 2009, 100, 233-239.
16. Troen, A. M.; Mitchell, B.; Sorensen, B.; Wener, M. H.; Johnston, A.; Wood, B.; Selhub, J.; McTiernan, A.; Yasui, Y.; Oral, E.; Potter, J. D.; Ulrich, C. M. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr., 2006, 136, 189-194.
17. Blount, B. C.; Mack, M. M.; Wehr, C. M.; MacGregor, J. T.; Hiatt, R. A.; Wang, G.; Wickramasinghe, S. N.; Everson, R. B.; Ames, B. N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U S A, 1997, 94, 3290-3295.
18. Ames, B. N.; Wakimoto, P. Are vitamin and mineral deficiencies a major cancer risk? Nat. Rev. Cancer, 2002, 2, 694-704.
19. Duthie, S. J.; Hawdon, A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J., 1998, 12, 1491-1497.
20. Pogribny, I. P.; Basnakian, A. G.; Miller, B. J.; Lopatina, N. G.; Poirier, L. A.; James, S. J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res., 1995, 55,1894-1901.
21. James, S. J.; Miller, B. J.; Basnakian, A. G.; Pogribny, I. P.; Pogribna, M.; Muskhelishvili, L. Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. Carcinogenesis, 1997, 18,287-293.
22. Jang, H.; Mason, J. B.; Choi, S. W. Genetic and epigenetic interactions between folate and aging in carcinogenesis. J Nutr., 2005, 135(12 Suppl), 2967S-2971S.
23. Crott, J. W.; Choi, S. W.; Branda, R. F.; Mason, J. B. Accumulation of mitochondrial DNA deletions is age, tissue and folate-dependent in rats. Mutat. Res., 2005, 570, 63-70.
24. Nelson, W. G.; De Marzo, A. M.; Yegnasubramanian, S. Epigenetic alterations in human prostate cancers. Endocrinology, 2009, 150, 3991-4002.
25. Schulz, W. A.; Hoffmann, M. J. Epigenetic mechanisms in the biology of prostate cancer. Semin. Cancer Biol., 2009, 19, 172-180.
26. Vanaja, D. K.; Ehrich, M.; Van den Boom, D.; Cheville, J. C.; Karnes, R. J.; Tindall, D. J.; Cantor, C. R.; Young, C. Y. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest., 2009, 27, 549-560.
27. Mudd, S. H.; Brosnan, J. T.; Brosnan, M. E.; Jacobs, R. L.; Stabler, S. P.; Allen, R. H.; Vance, D. E.; Wagner, C. Methyl balance and transmethylation fluxes in humans. Am. J. Clin. Nutr., 2007, 85, 19-25.
28. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li,Y,.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 2009, 457,910-914.
29. Casero, R. A., Jr.; Marton, L. J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov., 2007, 6,373-390.
30. Bistulfi, G.; Diegelman, P.; Foster, B. A.; Kramer, D. L.; Porter, C. W.; Smiraglia, D. J. Polyamine biosynthesis impacts cellular folate requirements necessary to maintain S-adenosylmethionine and nucleotide pools. FASEB J., 2009, 23, 2888-2897.
31. Pogribny, I. P.; James, S. J.; Jernigan, S.; Pogribna, M. Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutat. Res., 2004, 548, 53-59.
32. Choi, S. W.; Friso, S.; Ghandour, H.; Bagley, P. J.; Selhub, J.; Mason, J. B Vitamin B-12 deficiency induces anomalies of base substitution and methylation in the DNA of rat colonic epithelium. J. Nutr., 2004, 134,750-755.
33. Kim, Y. I. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J. Nutr., 2005, 135, 2703-2709.
34. Powers, H. J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J. Nutr., 2005, 135 (Suppl), 2960S-2966S.
35. van Guelpen, B. Folate in colorectal cancer, prostate cancer and cardiovascular disease. Scand. J. Clin. Lab. Invest., 2007, 67, 459-473.
36. Hubner, R. A.; Houlston, R. S. Folate and colorectal cancer prevention. Br. J. Cancer, 2009, 100,233-239.
37. Mathers, J. C. Folate intake and bowel cancer risk. Genes Nutr., 2009, 4, 173-178.
38. Christman, J. K.; Sheikhnejad, G.; Dizik, M.; Abileah, S.; Wainfan, E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis, 1993, 14, 551-557.
39. Chandar, N.; Lombardi, B.; Locker, J. c-Myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc. Natl. Acad. Sci. U S A, 1989, 86, 2703-2707.
40. Tsujiuchi, T.; Tsutsumi, M.; Sasaki, Y.; Takahama, M.; Konishi, Y. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats. Jpn. J. Cancer Res., 1999, 90, 909-913.
41. Fang, J. Y.; Xiao, S. D.; Zhu, S. S.; Yuan, J. M.; Qiu, D. K.; Jiang, S. J. Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. J Gastroenterol., 1997. 32,171-175.
42. Lu, R.; Wang, X.; Sun, D. F.; Tian, X. Q.; Zhao, S. L.; Chen, Y. X.; Fang, J. Y. Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer. Epigenetics, 2008, 3, 330-335.
43. Kuttler, F.; Mai, S. c-Myc, Genomic Instability and Disease. Genome Dyn., 2006, 1,171-190.
44. Bernard, D.; Pourtier-Manzanedo, A.; Gil, J.; Beach, D. H. Myc confers androgen-independent prostate cancer cell growth. J. Clin. Invest., 2003, 112,1724-1731.
45. Williams, K.; Fernandez, S.; Stien, X.; Ishii, K.; Love, H. D.; Lau, Y. F.; Roberts, R. L.; Hayward, S, W. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate, 2005, 63, 369-384.
46. Ribeiro, F. R.; Henrique, R.; Martins, A. T.; Jerónimo, C.; Teixeira, M. R. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Eur. Urol., 2007, 52, 116-125.
47. Gurel, B.; Iwata, T.; Koh, C. M.; Jenkins, R. B.; Lan, F.; Van Dang, C.; Hicks, J. L.; Morgan, J.; Cornish, T. C.; Sutcliffe, S.; Isaacs, W. B.; Luo, J.; De Marzo, A. M. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod. Pathol., 2008, 21, 1156-1167.
48. He, M.; Vanaja, D. K.; Karnes, R. J.; Young, C. Y. Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells. Prostate, 2009, 69, 1643-1650.
49. Liu, Z.; Choi, S. W.; Crott, J. W.; Smith, D. E.; Mason, J.B. Multiple B-vitamin inadequacy amplifies alterations induced by folate depletion in p53 expression and its downstream effector MDM2. Int. J. Cancer, 2008, 123, 519-525.
50. Liu, Z,.; Choi, S. W.; Crott, J. W.; Keyes, M. K.; Jang, H.; Smith, D. E.; Kim, M.; Laird, P. W.; Bronson, R.; Mason, J. B. Mild depletion of dietary folate combined with other B vitamins alters multiple components of the Wnt pathway in mouse colon. J. Nutr., 2007, 137, 2701-2708.
51. Duthie, S. J.; Grant, G.; Pirie, L. P.; Watson, A. J.; Margison,G. P. Folate Deficiency Alters Hepatic and Colon MGMT and OGG-1 DNA Repair Protein Expression in Rats but Has No Effect on Genome-Wide DNA Methylation. Cancer Prev. Res., 2010, 3, 92-100.
52. Dobosy J, R.; Fu, V. X.; Desotelle, J. A.; Srinivasan, R.; Kenowski, M. L.; Almassi, N.; Weindruch, R.; Svaren, J.; Jarrard, D. F. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. Prostate, 2008, 68, 1187-1195.
53. Novakovic, P.; Stempak, J. M.; Sohn, K. J.; Kim, Y. I. Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis, 2006, 27, 916-924.
54. Crott, J. W.; Liu, Z.; Keyes, M. K.; Choi, S. W.; Jang, H.; Moyer, M. P.; Mason, J. B. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J. Nutr. Biochem., 2008, 19, 328-335.
55. Weinstein, S. J.; Hartman, T. J.; Stolzenberg-Solomon, R.; Pietinen, P.; Barrett, M. J.; Taylor, P. R.; Virtamo, J.; Albanes, D. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 1271-1272.
56. Weinstein, S. J.; Stolzenberg-Solomon, R.; Pietinen, P.; Taylor, P. R.; Virtamo, J.; Albanes, D. Dietary factors of one-carbon metabolism and prostate cancer risk. Am. J. Clin. Nutr., 2006, 84, 929-935.
57. Hultdin, J.; Van Guelpen, B.; Bergh, A.; Hallmans, G.; Stattin, M. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study. Int. J. Cancer 2005, 113, 819-824.
58. Johansso, M.; Appleby, P. N.; Allen, N. E.; Travis, R. C.; Roddam, A. W.; Egevad, L.; Jenab, M.; Rinaldi, S.; Kiemeney, L. A.; Bueno-de-Mesquita, H. B.; Vollset, S. E.; Ueland, P. M.; Sánchez, M. J.; Quirós, J. R.; González, C. A.; Larrañaga, N.; Chirlaque, M. D.; Ardanaz, E.; Sieri, S.; Palli, D.; Vineis, P.; Tumino, R.; Linseisen, J.; Kaaks, R.; Boeing, H.; Pischon, T.; Psaltopoulou, T.; Trichopoulou, A.; Trichopoulos, D.; Khaw, K. T.; Bingham, S.; Hallmans, G.; Riboli, E.; Stattin, P.; Key, T. J. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 279-285.
59. Stevens, V. L.; Rodriguez, C.; Pavluck, A. L.; McCullough, M. L.; Thun, M. J.; Calle, E. E. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am. J. Epidemiol., 2006, 163, 989-996.
60. Johansson, M.; Van Guelpen, B.; Vollset, S. E.; Hultdin, J.; Bergh, A.; Key, T.; Midttun, O.; Hallman, G.; Ueland, P. M.; Stattin, P. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol. Biomarkers Prev., 2009, 18, 1538-1543.
61. Kasperzyk, J. L.; Fall, K.; Mucci, L. A.; Håkansson, N.; Wolk, A.; Johansson, J. E.; Andersson, S. O.; Andrén, O. One-carbon metabolism-related nutrients and prostate cancer survival. Am. J. Clin. Nutr., 2009, 90, 561-569.
62. Rossi, E.; Hung, J.; Beilby, J. P.; Knuiman, M. W.; Divitini, M. L.; Bartholomew, H. Folate levels and cancer morbidity and mortality: Prospective cohort study from Busselton, Western Australia. Ann. Epidemiol., 2006, 16, 206-212.
63. Pelucchi, C.; Galeone, C.; Talamini, R.; Negri, E.; Parpinel, M.; Franceschi, S.; Montella, M.; La Vecchia, C. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 944-948.
64. Figueiredo, J. C.; Grau, M. V.; Haile, R. W.; Sandler, R. S.; Summers, R. W.; Bresalier, R. S, Burke, C. A.; McKeown-Eyssen, G. E.; Baron, J. A. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J. Natl. Cancer Inst., 2009, 101, 432-435.
65. Shannon, J.; Phoutrides, E.; Palma, A.; Farris, P.; Peters, L.; Forester, A.; Tillotson, C. J.; Garzotto, M. Folate intake and prostate cancer risk: a case-control study. Nutr. Cancer, 2009, 61, 617-628.
66. Ebbing, M.; Bønaa, K. H.; Nygård, O.; Arnesen, E.; Ueland, P. M.; Nordrehaug, J. E.; Rasmussen, K.; Njølstad, I.; Refsum, H.; Nilsen, D. W.; Tverdal, A.; Meyer,K.; Vollset, S. E. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA, 2009, 302, 2119-2126.
67. Singal, R.; Ferdinand, L.; Das, P. M.; Reis, I. M.; Schlesselman, J. J.; Polymorphisms in the methylenetetrahydro-folate reductase gene and prostate cancer risk. Int. J. Oncol., 2004, 25, 1465-1471.
68. Cicek, M. S.; Nock, N. L.; Li, L.; Conti, D. V.; Casey, G.; Witte, J. S. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 1331-1336.
69. Van Guelpen, B.R.; Wirén, S. M.; Bergh, A. R.; Hallmans, G.; Stattin, P. E.; Hultdin, J. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur. J. Cancer Prev., 2006, 15, 46-50.
70. Marchal, C.; Redondo, M.; Reyes-Engel, A.; Perea-Milla, E.; Gaitan, M. J.; Machuca, J.; Diaz, F.; Caballero, J.; Carnero, J Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur. J. Surg. Oncol., 2008, 34, 805-810.
71. Muslumanoglu, M. H.; Tepeli, E.; Demir, S.; Uludag, A.; Uzun, D.; Atli, E.; Canturk, K. M.; Ozdemir, M.; Turgut, M. The analysis of the relationship between A1298C and C677T polymorphisms of the MTHFR gene with prostate cancer in Eskisehir population. Genet. Test Mol. Biomarkers, 2009, 13, 641-645.
72. Bai, J. L.; Zheng, M. H.; Xia, X.; Ter-Minassian, M.; Chen, Y. P.; Chen, F. MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and2762 controls. Eur. J. Cancer, 2009, 45, 1443-1449.
73. Collin, S. M.; Metcalfe, C.; Zuccolo, L.; Lewis, S. J.; Chen, L.; Cox, A.; Davis, M.; Lane, J. A.; Donovan, J.; Smith, G. D.; Neal, D. E.; Hamdy, F. C.; Gudmundsson, J.; Sulem, P.; Rafna, T.; Benediktsdottir, K. R.; Eeles, R. A.; Guy, M.; Kote-Jarai, Z.; UK Genetic Prostate Cancer Study Group.; Morrison, J.; Al Olama, A. A.; Stefansson, K.; Easton, D. F.; Martin, R. M. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev., 2009, 18, 2528-2539.
74. Stevens, V. L.; Rodriguez, C.; Sun, J.; Talbot, J. T.; Thun, M. J.; Calle, E. E. No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 3612-3614.
75. Bistulfi, G.; Vandette, E.; Matsui, S. I.; Smiraglia, D. J. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol., 2010, 8, 6.